A Phase 1 study to evaluate the Safety, Tolerability and Pharmacokinetics of CT P59 in Healthy Subjects : A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel Group, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of CT P59 in Healthy Subjects

Medienart:

Klinische Studie

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

WHO International Clinical Trials Registry Platform - (2022) vom: 11. Jan. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: ;Not Applicable
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2020-12-14, Last updated: 2022-11-24

ICTRP ID:

KCT0005673
NCT04525079

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO004983092